Suppr超能文献

血清 S100 钙结合蛋白 A12 浓度在社区获得性肺炎患者中的临床意义。

Clinical significance of serum S100 calcium-binding protein A12 concentrations in patients with community-acquired pneumonia.

机构信息

Department of Respiratory and Critical Care Medicine, Xichang People's Hospital, Xichang City, Sichuan Province, China.

Department of Pharmacy, Xichang People's Hospital, Xichang City, Sichuan Province, China.

出版信息

J Int Med Res. 2023 Aug;51(8):3000605231191021. doi: 10.1177/03000605231191021.

Abstract

OBJECTIVE

This study aimed to investigate the clinical significance of serum S100 calcium-binding protein A12 (S100A12) concentrations in patients with community-acquired pneumonia (CAP).

METHODS

This was a case-control study. We selected 120 patients with CAP treated in Xichang People's Hospital from January to June 2022 as the case group. Sixty healthy adults without a history of basic diseases were selected as the control group. The patients in the case group were divided into the low S100A12 and high S100A12 subgroups. Serum S100A12, C-reactive protein (CRP), and procalcitonin (PCT) concentrations, the leukocyte count, and other study parameters were compared.

RESULTS

Serum S100A12, CRP, and PCT concentrations and the leukocyte count were higher in the case group than in the control group. The baseline confusion, urea, respiratory rate, blood pressure, and age ≥ 65 score, baseline pneumonia severity index score, and 30-day mortality rate were higher in the high S100A12 subgroup than in the low S100A12 subgroup. Serum CRP and PCT concentrations and the leukocyte count were higher in the high S100A12 subgroup than in the low S100A12 subgroup.

CONCLUSION

Patients with high serum S100A12 concentrations have more severe CAP, a more serious inflammatory reaction, and higher 30-day mortality.

摘要

目的

本研究旨在探讨血清 S100 钙结合蛋白 A12(S100A12)浓度在社区获得性肺炎(CAP)患者中的临床意义。

方法

这是一项病例对照研究。我们选择了 2022 年 1 月至 6 月在西昌人民医院治疗的 120 例 CAP 患者作为病例组。选择 60 名无基础疾病史的健康成年人作为对照组。将病例组患者分为低 S100A12 组和高 S100A12 组。比较血清 S100A12、C 反应蛋白(CRP)和降钙素原(PCT)浓度、白细胞计数等研究参数。

结果

病例组血清 S100A12、CRP 和 PCT 浓度及白细胞计数均高于对照组。高 S100A12 组的基线意识障碍、尿素、呼吸频率、血压、年龄≥65 分、基线肺炎严重指数评分和 30 天死亡率均高于低 S100A12 组。高 S100A12 组血清 CRP 和 PCT 浓度及白细胞计数均高于低 S100A12 组。

结论

血清 S100A12 浓度较高的患者 CAP 更严重,炎症反应更严重,30 天死亡率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f615/10467374/94988580d275/10.1177_03000605231191021-fig1.jpg

相似文献

3
5
Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
Clin Chem Lab Med. 2019 Sep 25;57(10):1632-1637. doi: 10.1515/cclm-2019-0175.
6
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Eur Respir J. 2008 Feb;31(2):349-55. doi: 10.1183/09031936.00054507. Epub 2007 Oct 24.
7
High ratio of C-reactive protein/procalcitonin predicts infection among adults hospitalized with community acquired pneumonia.
Scand J Clin Lab Invest. 2021 Feb;81(1):65-71. doi: 10.1080/00365513.2020.1858491. Epub 2020 Dec 21.
8
Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Korean J Lab Med. 2010 Aug;30(4):406-13. doi: 10.3343/kjlm.2010.30.4.406.
9
Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia.
Respirology. 2016 Nov;21(8):1459-1464. doi: 10.1111/resp.12846. Epub 2016 Jul 11.

本文引用的文献

1
New testing guidelines for community-acquired pneumonia.
Curr Opin Infect Dis. 2022 Apr 1;35(2):128-132. doi: 10.1097/QCO.0000000000000824.
5
7
C-reactive protein levels in the early stage of COVID-19.
Med Mal Infect. 2020 Jun;50(4):332-334. doi: 10.1016/j.medmal.2020.03.007. Epub 2020 Mar 31.
10
The role of S100A12 as a systemic marker of inflammation.
Int J Inflam. 2012;2012:907078. doi: 10.1155/2012/907078. Epub 2012 Jul 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验